methyldopa has been researched along with 2019 Novel Coronavirus Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Legkova, KS; Topchy, TB; Volchkova, EA | 1 |
1 other study(ies) available for methyldopa and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
[COVID-19 as a trigger of autoimmune hepatitis. Case report].
Topics: Adult; Antiviral Agents; COVID-19; Diclofenac; Etanercept; Female; Hepatitis, Autoimmune; Humans; Infliximab; Male; Methyldopa; Minocycline | 2022 |